CN Patent

CN102395373A — 按需避孕方法

Assigned to Laboratoire HRA Pharma SAS · Expires 2012-03-28 · 14y expired

What this patent protects

本发明涉及用于按需避孕的方法，所述方法包含在性交前72小时内或性交后120小时内向女性给药孕激素药剂或孕酮受体调节剂例如17α-乙酰氧基-11β-[4-N，N-二甲基氨基-苯基]-19-去甲孕甾-4，9-二烯-3，20-二酮(醋酸乌利司他)。

USPTO Abstract

本发明涉及用于按需避孕的方法，所述方法包含在性交前72小时内或性交后120小时内向女性给药孕激素药剂或孕酮受体调节剂例如17α-乙酰氧基-11β-[4-N，N-二甲基氨基-苯基]-19-去甲孕甾-4，9-二烯-3，20-二酮(醋酸乌利司他)。

Drugs covered by this patent

ulipristal-acetate (ULIPRISTAL ACETATE)

Patent Metadata

Patent number: CN102395373A
Jurisdiction: CN
Classification: —
Expires: 2012-03-28
Drug substance claim: No
Drug product claim: No
Assignee: Laboratoire HRA Pharma SAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.